These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 25722426)

  • 1. Concise review: making and using clinically compliant pluripotent stem cell lines.
    Carpenter MK; Rao MS
    Stem Cells Transl Med; 2015 Apr; 4(4):381-8. PubMed ID: 25722426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation of pluripotent stem cells for regenerative medicine.
    Li K; Kong Y; Zhang M; Xie F; Liu P; Xu S
    Biochem Biophys Res Commun; 2016 Feb; 471(1):1-4. PubMed ID: 26851367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives and future directions of human pluripotent stem cell-based therapies: lessons from Geron's clinical trial for spinal cord injury.
    Lukovic D; Stojkovic M; Moreno-Manzano V; Bhattacharya SS; Erceg S
    Stem Cells Dev; 2014 Jan; 23(1):1-4. PubMed ID: 23980630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges and approaches to the culture of pluripotent human embryonic stem cells.
    Skottman H; Narkilahti S; Hovatta O
    Regen Med; 2007 May; 2(3):265-73. PubMed ID: 17511563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells.
    Lee J; Dykstra B; Sackstein R; Rossi DJ
    Curr Opin Hematol; 2015 Jul; 22(4):317-23. PubMed ID: 26049752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cGMP-Manufactured Human Induced Pluripotent Stem Cells Are Available for Pre-clinical and Clinical Applications.
    Baghbaderani BA; Tian X; Neo BH; Burkall A; Dimezzo T; Sierra G; Zeng X; Warren K; Kovarcik DP; Fellner T; Rao MS
    Stem Cell Reports; 2015 Oct; 5(4):647-59. PubMed ID: 26411904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent Stem Cell Heterogeneity.
    Hayashi Y; Ohnuma K; Furue MK
    Adv Exp Med Biol; 2019; 1123():71-94. PubMed ID: 31016596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines.
    Drukker M
    Semin Immunol; 2008 Apr; 20(2):123-9. PubMed ID: 18160306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of hematopoietic cells derived from pluripotent stem cells.
    Bouhassira EE
    Expert Opin Biol Ther; 2013 Aug; 13(8):1099-102. PubMed ID: 23611514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
    Abbasalizadeh S; Baharvand H
    Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells: current challenges and future promise.
    Battey JF
    Dev Dyn; 2007 Dec; 236(12):3193-8. PubMed ID: 17584855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of rabbit pluripotent stem cell lines.
    Tancos Z; Nemes C; Polgar Z; Gocza E; Daniel N; Stout TA; Maraghechi P; Pirity MK; Osteil P; Tapponnier Y; Markossian S; Godet M; Afanassieff M; Bosze Z; Duranthon V; Savatier P; Dinnyes A
    Theriogenology; 2012 Nov; 78(8):1774-86. PubMed ID: 22925641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of pluripotent embryonic-like stem cells residing in adult tissues in regeneration and longevity.
    Ratajczak MZ; Liu R; Ratajczak J; Kucia M; Shin DM
    Differentiation; 2011 Mar; 81(3):153-61. PubMed ID: 21339038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards generation of human haematopoietic stem cells.
    Wahlster L; Daley GQ
    Nat Cell Biol; 2016 Nov; 18(11):1111-1117. PubMed ID: 27723718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospects for pluripotent stem cell-derived cardiomyocytes in cardiac cell therapy and as disease models.
    Freund C; Mummery CL
    J Cell Biochem; 2009 Jul; 107(4):592-9. PubMed ID: 19449339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent stem cells: the last 10 years.
    Kimbrel EA; Lanza R
    Regen Med; 2016 Dec; 11(8):831-847. PubMed ID: 27908220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.